02/27/2026
Immunocidin has benefitted many of our patients, from initial diagnosis to palliative care.
Reach out to us if you’d like to learn more about this innovative therapy.
Our hearts go out to Dolly’s family 💕
Dolly sadly passed earlier this month. NovaVive was pleased to help her live comfortably with Immunocidin therapy for more than four years after her cancer diagnosis.
Immunocidin immunotherapy is regulator-approved in the USA and Canada for the treatment of canine mammary cancer, but it is being used experimentally to treat a variety of other cancer types, including osteosarcoma.
Immunocidin has also proven helpful as a palliative (end-of-life) support for dogs when treatment is no longer an option.
Learn more at NovaVive.ca/products or ask your veterinarian to contact us.